GINA 2015: The latest iteration of a magnificent journey

European Respiratory Journal

Volumn 46, Issue 3, 2015, Pages 579-582

  Bousquet, Jean ^a,b,c   Humbert, Marc ^d,e,f  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b EIP AHA reference Site   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e BICÊTRE HOSPITAL   (France)

^f Universite Paris Sud   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS DEVELOPMENT; DECISION SUPPORT SYSTEM; EDITORIAL; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STRATEGIC PLANNING; WHEEZING; DISEASE MANAGEMENT; DOCUMENTATION; EUROPE; FEMALE; HEALTH; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ASTHMA; DISEASE MANAGEMENT; DOCUMENTATION; EUROPE; FEMALE; GLOBAL HEALTH; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84942784588     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01084-2015     Document Type: Editorial

References (34)

1. Guidelines for management of asthma in adults: I-Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ 1990; 301: 651-653.
2. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007; 62: 102-112.
3. Boulet LP, Becker A, Berube D, et al. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ 1999; 161: Suppl. 11, S1-S61.
4. Roche N, Godard P. Control and severity: complementary approaches to asthma management. Allergy 2007; 62: 116-119.
5. Busse WW, Lemanske RF Jr. Expert Panel Report 3: Moving forward to improve asthma care. J Allergy Clin Immunol 2007; 120: 1012-1014.
6. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
7. Boulet LP, FitzGerald JM, Reddel HK. The revised 2014 GINA strategy report: opportunities for change. Cur Opin Pulm Med 2015; 21: 1-7.
8. Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015; 46: 622-639.
9. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.
10. Herland K, Akselsen JP, Skjonsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 2005; 99: 11-19.
11. Price D, Chisholm A, van der Molen T, et al. Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness. Curr Allergy Asthma Rep 2011; 11: 526-538.
12. Zhang H, Gustafsson M, Nestor C, et al. Targeted omics and systems medicine: personalising care. Lancet Respir Med 2014; 2: 785-787.
13. Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med 2011; 155: 97-107.
14. Goeman DP, Abramson MJ, McCarthy EA, et al. Asthma mortality in Australia in the 21st century: a case series analysis. BMJ Open 2013; 3: e002539.
15. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 2012; 23: 1-298.
16. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 2000; 162: 1391-1396.
17. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
18. Hanania NA, King MJ, Braman SS, et al. Asthma in the elderly: current understanding and future research needs - a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol 2011; 128: Suppl. 3, S4-S24.
19. Boulet LP. Is asthma control really more difficult to achieve in the elderly patient? Int Arch Allergy Immunol 2014; 165: 149-151.
20. Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 2009; 64: 669-677.
21. de Marco R, Marcon A, Rossi A, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J 2015; 46: 671-679.
22. Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014; 44: 341-350.
23. Ernst P, Saad N, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence. Eur Respir J 2015; 45: 525-537.
24. Brand PL, Caudri D, Eber E, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43: 1172-1177.
25. Pinart M, Benet M, Annesi-Maesano I, et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014; 2: 131-140.
26. Boulet LP, FitzGerald JM, Levy ML, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012; 39: 1220-1229.
27. Bousquet J, Khaltaev N, Cruz A, et al. International European Respiratory Society/American Thoracic Society guidelines on severe asthma. Eur Respir J 2014; 44: 1377-1378.
28. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
29. Bousquet J, Jorgensen C, Dauzat M, et al. Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies. Curr Pharm Des 2014; 20: 5928-5944.
30. Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J 2014; 44: 304-323.
31. Bousquet J, Michel J, Standberg T, et al. The European Innovation Partnership on Active and Healthy Ageing: the European Geriatric Medicine introduces the EIP on AHA Column. Eur Geriatr Med 2014; 5: 361-362.
32. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670.
33. Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Evid Based Child Health 2014; 9: 829-930.
34. Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy 2015; in press [DOI: 10.1111/all.12686].